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Background: Moxibustion is one of the most commonly used therapies in acupuncture practice, and is
demonstrated to be beneficial for patients with diarrhea from irritable bowel syndrome (D-IBS). But its mechanism
remains unclear. Because visceral hypersensitivity in IBS patients has been documented by evaluation of perceived
stimulations through functional magnetic resonance imaging (fMRI) studies, we focused on observing brain
imaging changes in D-IBS patients during rectal balloon distention before and after moxibustion in order to reveal
its possible central mechanism and further evaluate its effect.
Methods: This clinical trial is registered under the number: ChiCTR-TRC-10000887. Eighty D-IBS patients were
randomly divided into a moxibustion and sham moxibustion group (control group) for a 4-week treatment. Fifteen
patients in moxibustion group and thirteen patients in control group completed two fMRI scans during a 50 and
100 ml rectal balloon distention before and after treatment. Rectal pain were obtained with a scan test. Birmingham
IBS Symptom Scale and IBS Quality of Life (QOL) Scale were used to evaluate therapeutic effect.
Results: After treatment, the decrease in Birmingham IBS Symptom Scale and IBS QOL Scale scores in moxibustion
group was significantly greater than that of control group (P < 0.01). The defecation urge threshold and the pain
perception threshold of moxibustion group was also significantly higher after treatment than that of control group
(P < 0.01). The decrease in pain score during the 100 ml rectal balloon distention in moxibustion group was
significantly greater than that of control group (P < 0.05). There was no definite activated center during the 50 ml
rectal distention in either group before treatment. After treatment, the prefrontal cortex (PFC) was affected in
moxibustion group, while the PFC and the anterior cingulated cortex (ACC) were affected in control group. During
the 100 ml distention before treatment in both groups, the PFC and ACC were activated. After treatment, they
disappeared in moxibustion group but remained in control group.
Conclusions: Moxibustion can improve symptoms and quality of life in D-IBS patients. It can also decrease rectal
sensitivity. The activation of PFC and ACC during a 100 ml rectal distention disappeared after moxibustion treatment.
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Irritable bowel syndrome (IBS) is a lasting condition in-
volving recurrent attacks of a group of clinical symptoms
including abdominal pain, distention, bowel habit changes,
and abnormal stool. It is a common gastrointestinal (GI)
disorder, affecting 10–15% of the population in developed
countries. The global prevalence rate of IBS is 11.2% [1]
the prevalence in western countries is from 4.7% to 25%
while it’s from 6.5% to 10.1% in eastern countries [2]. In
China, it’s about 4.6%-5.67% [3]. Among IBS patients in
China, 74.1% of them are diarrhea predominant IBS(D-
IBS), which is the most common type[4]. Traditional
Chinese medicine has long been used to treat IBS. A
Meta-analysis showed acupuncture exhibits clinically and
statistically significant controls of IBS symptoms [5]. Stud-
ies showed that in comparative effectiveness Chinese tri-
als, patients reported greater benefits from acupuncture
than from pharmacological therapies [6,7]. One study
finding s indicate that Acu/Moxa treatment shows prom-
ise in the area of symptom management for IBS [8]. In
fact, moxibustion treatment for D-IBS has been shown to
have a good clinical effect [9,10]. It can effectively relieve
diarrhea, abdominal pain, abdominal distension, and other
symptoms [11]. Chen Sheng et al. found that moxibustion
treatment had better results than Pinaverium [12]. Al-
though the risk of bias in some included studies is rela-
tively high, one systematic review and meta-analysis
suggests that moxibustion may provide benefits to IBS pa-
tients [13]. Guangqing An et al. found that acupuncture–
moxibustion is more effective than medication for treating
IBS. Moreover, moxibustion is often more easily accepted
by patients [14]. Therefore, moxibustion helps D-IBS pa-
tients improve their symptoms, although its mechanism
remains unclear.
In recent years, the visceral hypersensitivity of IBS pa-
tients has received much attention. Visceral hypersensi-
tivity relates to stress, emotions, and the brain–gut axis
[15-17]. Increased sensitivity of the rectum is seen in al-
most all IBS patients, especially from stimulation, such
as rectal balloons or mechanical stimulation. Visceral
sensitivity, rectal sensory thresholds, and compliance of
patients with D-IBS were found to be significantly higher
than those in control patients [18-20]. Weak stimulation,
which does not result in a response from normal pa-
tients, can produce the perception of IBS. Equal sublim-
inal stimulations cause a greater response in IBS patients
than those in control patients [21].
Rapid developments in functional brain imaging have
led to the visual observation of central visceral pain, and
activities in areas of the brain. A recent meta-analysis of
published studies on brain responses to rectal distension
supports the conclusion that brain responses to rectal
distension differ between IBS patients and healthy con-
trols(HCs) [22]. Moreover, cerebral cortex blood flow,glucose metabolic rate, and potential activities of IBS are
not the same as those in control groups [23,24]. Al-
though the results of brain imaging studies on IBS are
not entirely consistent, they suggest that visceral hyper-
sensitivity in IBS patients could relate to nerve centers,
and especially the dysregulation of the pain nerve center.
Moxibustion can effectively relieve the symptoms of
D-IBS such as diarrhea, abdominal pain, and abdominal
discomfort. However, further assessments are needed to
explain the therapeutic effects because there are no
studies fully explaining the central mechanisms of moxi-
bustion. The aim of this study was to examine changes
in the brain imaging of D-IBS patients via functional
magnetic resonance imaging (fMRI) during rectal bal-
loon distention before and after moxibustion to under-




Eighty right-handed patients were recruited from the
outpatient clinic of Shanghai Research Institute of Acu-
puncture and Meridian and the Shanghai Community
Health Service Center of Shi Men Er Road from April
2010 to November 2011. Each patient met the Rome III
criteria of D-IBS. The enrolled patients were randomly
divided into a moxibustion group (n = 40) or a sham
moxibustion group (control group) (n = 40) using a
computer-generated randomization sequence. The se-
quence was concealed from the care providers through
the use of sealed, opaque, sequentially numbered enve-
lopes. Patients were blinded to group assignment. Exclu-
sion criteria in both groups included patients with:
clinically relevant gastrointestinal, hepatic, or other sys-
temic diseases; bowel resections or abdominal opera-
tions; any medication administered in preceding 30 days;
pregnancy or lactation; or epilepsy.
Forty patients in the moxibustion group and 39 patients
in control group finished the treatment intervention. One
patient in the control group dropped out after several
treatments because of pregnancy. After explaining the
fMRI procedure to the included patients, 46 patients de-
clined the rectal balloon distension. Thirty-three patients
agreed to have the fMRI test. Among them, 18 patients
were in the moxibustion group and 15 were in the control
group. Fifteen patients in the moxibustion group com-
pleted two fMRI scans. Three patients in the moxibustion
group withdrew from the study. Reasons for discontinu-
ation included: abdominal pain during the experimental
procedure (n = 1), and the inability to finish the rectal bal-
loon distention test after having the first fMRI (n = 2).
Thirteen patients in the control group completed two
fMRI scans. Two patients in the control group dropped
out from an inability to finish the rectal balloon distention
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males, nine males) (mean 47.5 ± 0.896 years, range 41–53)
and 13 patients in control group (six females, seven males)
(mean 40.9 ± 10.136 years, range 35–47) finished the
study. The flow chart of the clinical trials is shown in
Figure 1.
The clinical trial number of this study is: ChiCTR-
TRC-10000887. The study protocol was approved by
Ethics Committee of Shanghai traditional Chinese Medi-
cine University affiliated Yue Yang hospital of Integrated
Traditional Chinese and Western medicine, Shanghai
University of Traditional Chinese Medicine in March
2010 (Authorization No. 2010–01; issue date: 3rd of
March 2010). Written informed consent was obtained
from each participant.
Treatment
Acupoints Tianshu (ST25), Qihai (RN6), and Zhongwan
(RN12) were used in the moxibustion group. Aconite
cakes (specially molded with a diameter of 2.5 cm,
height of 1 cm, and weight of 5.8 g) were put on theFigure 1 The consort flow chart.above points and burning moxa (from Nanyang, China,
moxa cone of 1.5 cm in diameter, 1.5 cm in height, and
1.6 g in weight) were placed on the cakes. One moxa cone
was used for each treatment, three times per week for two
weeks as a course of treatment. Every patient had two
courses of treatment. In the control group, the same acon-
ite cakes and moxa cones were used. However, round
cardboard pieces (2 cm in diameter, 1.14 g in weight) were
placed under the aconite cakes. The treatment course was
the same as that of the moxibustion group. The locations
of the acupoints are shown in Figure 2.
Clinical assessments
The Birmingham IBS Symptom Scale was used to rate pa-
tient symptoms. The score includes multiple dimensions
that cover 14 representative and relevant questions of IBS
[25]. Symptoms are graded on a six point scale: none of
the time (0 point), a little of the time (1 point), some of
the time (2 points), a good bit of the time (3 points), most
of the time (4 points), all of the time (5 points). The IBS
QOL Scale [26] was used to compare the quality of life of
Figure 2 Locations of acupoint (LineA: RenMeridian, LineB: Stomach Meridian). The acupoints were located as follows: (i) ST25(Tianshu), 2
cun lateral to the centre of the umbilicus; (ii)Ren12(Zhongwan), on the middle of the abdomen, 4 cun above the umbilicus; (iii)Ren6(Qihai), on
the midline of the abdomen,1.5cun below the umbilicus. It’s 8 cun from xiphoid process to the center of the umbilicus and 5cun between the
center of the umbilicus and the upper border of symphysis pubis.
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structures are: dysphoria, interference with activity, body
image, health worry, food avoidance, social reaction, sex-
ual, and relationship. The scores are divided into five
levels: not at all (1 point), slightly (2 points), moderately (3
points), quite a bit (4 points), and extremely or a great deal
(5 points). All scores from these two scales for patients in
both groups before and after treatment were recorded.
Lower scores indicate milder symptoms and better QOL.
Statistical analysis
Sample size
Because there was no reference to indicate the effect size
that could be expected from the use of moxibustion to
treat IBS with diahhra, we did not estimate the sample size
based on a power calculation. Instead, we enrolled 80 par-
ticipants with a 20% withdrawal rate to provide 32 patients
in each group in order to meet the number more than that
of the requirement of minimum sample size.
Clinical variables
The scores of the Birmingham IBS Symptom Scale and
IBS QOL Scale were analyzed with SPSS 18.0. Repeated
measure was used for statistical comparison.
Brain fMRI scans
Stimulation
Rectal stimulation was performed by distending a custom-
designed polyethylene balloon (50 mm in length, 20 mmin diameter, and a maximum volume of 320 ml, Hefei
Austrian Bio-technology Co. Ltd, Hefei, China). The bal-
loon was attached to a plastic injector via a 30-cm-long
tube. The balloon could be inflated with air from the in-
jector. Rectal balloon distention stimulation on the rectum
was presented in separate functional runs conducted dur-
ing two different sessions with the stimulus order counter
balanced across sessions. For each subject, the balloon
catheter was passed perianally and positioned in the rec-
tum 10 to 15 cm above the anus at the start of the visceral
experiment. The stimulation sequences were identical,
consisting of two stimulus intensities: “high”, which dis-
tended the balloon with 100 ml of air, and “low,” which
distended the balloon with 50 ml of air.
Each patient was scanned by fMRI under rectal bal-
loon distention before and after treatment. Each test
subject was recorded before the injection of gas for dif-
ferent feeling intensities, including initial feeling thresh-
olds, urgent defecation perception threshold, and pain
perception threshold. Then, the rectal pain score (Visual
analog scale: 0 = none to 10 = unbearable) of the subjects
during balloon gas injection to 50 ml or 100 ml was re-
corded. These recorded data were analyzed with SPSS
18.0 and the paired samples test was used for statistical
comparison.
Imaging procedure
MRI was performed using a 1.5 T GE Scanner (Exicte
HD, General Electric Medical System, Milwaukee, WI,
Table 1 Subject characteristics in both groups
Item Moxibustion group (n = 15) Control group (n = 13) P
Mean 95% CI Mean 95% CI
Age 47.47 ± 0.896 [41.48, 53.46] 40.92 ± 10.136 [34.8, 47.05] 0.112
Gender Male 9 —————— Male 7 ————— 0.743
Female 6 Female 6
Height 1.673 ± 0.886 [1.624, 1.722] 1.692 ± 0.8156 [1.643, 1.742] 0.563
Weight 66.67 ± 5.665 [63.53, 69.80] 68.46 ± 9.70 [62.6, 74.32] 0.565
Course of disease 3.0(2.0-5.0) [2.26, 8.47] 3.5(3.0-10.0) [3.39, 8.46] 0.352
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consisted of one anatomical scan and two functional
scanning runs. The anatomical scans were recorded
using a high-resolution T1-weighted anatomical protocol
(TR 8.1 ms, TE 60.0 ms, slice thickness 1.4 mm, FOV
24 cm × 18 cm). The functional scans were collected
using a blood-oxygen-level-dependent (BOLD) protocol
with a T2*-weighted gradient echo-planar imaging (EPI)
sequence (TR 3000 ms, TE 60 ms, flip angle 90°). The
scanning planes were oriented parallel to the anterior
commissure-posterior commissure line and covered the
whole brain from the base of the cerebellum to the top
of the cortex (32 slices, slice thickness 5 mm). The indi-
vidual scans consisted of 60 whole brain volume acquisi-
tions, divided into three cycles. Each cycle consisted of
30 s (ten successive volume acquisitions) with visceral
stimulation, followed by 30 s without stimulation. Extra
baseline (12 s) with no stimulation was added in the
beginning of each scanning run. So the total scan in-
cludes: simulation stage (30 s), resting stage (30 s),
simulation stage (30 s), resting stage (30 s), simulation
stage (30 s), resting stage (30 s), totally 180 s. Before
being positioned in the scanner, all subjects were
instructed to attend to the stimuli and refrain from
movement as much as possible. To further prevent
movement artifacts, the subject’s head was immobilized
with padded earmuffs and a foam headrest. Each sub-
ject was provided with earplugs to reduce the noise







Moxibustion Group 15 28.27 ± 6.64 9.00 ± 4.05 417.009 <0.001
Control Group 13 27.38 ± 3.95 21.46 ± 4.31 45.260 <0.001




P 0.679 <0.001Psychophysical ratings
Before each functional scanning run, subjects rated pain
intensity of the stimuli under 50 ml and 100 ml rectal
balloon distention on a 10-point scale. The anchors for
pain intensity were between “no pain sensation” and “ex-
tremely intense pain sensation”. If the stimulus was rated
as a zero on the pain intensity scale, the subject was
asked to rate the nonpainful sensation using “no sensa-
tion”. If the stimulus was rated as a ten, the subject was
asked to rate the maximum sensation using “extreme
pressure sensation”. To avoid head movement, all ratings
were nonverbal, using the fingers of one hand to indicate
perceptual estimates from 0 to 10.
Data analysis
BOLD fMRI images were analyzed using statistical para-
metric mapping 2 (SPM2) (Wellcome Department of
Cognitive Neurology, London, UK; http://www.fil.ion.ucl.
ac.uk/spm/software/spm2/). Correction for acceptable
head movement between the images in each session was
performed by alignment with one image. Each subject’s
realigned images were resliced to isotropic 2 mm 3 voxels
and normalized by linear and nonlinear transformations
into a standardized anatomical space (Montreal Neuro-
logical Institute). After normalization, a 5 mm (full width
half maximum) Gaussian filter was applied to each image.
SPM2 treats each voxel according to a general linear
model. For each condition, activated and deactivated







Moxibustion Group 15 80.33 ± 8.49 48.27 ± 7.69 485.324 <0.001
Control Group 13 80.54 ± 8.27 73.62 ± 7.42 97.200 <0.001
Totally Amount 28 80.43 ± 8.23 60.04 ± 14.86 527.472 <0.001
Comparison
between groups
F 0.004 78.191 – –
P 0.949 <0.001 – –
Table 4 Rectal distention threshold comparison
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Compared with baseline, ▲ p = 0.000, compared with the control group, ▲ p = 0.000, ★ p = 0.000.
























Figure 3 Pain score in both groups during 50mlrectal balloon distension.
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struct individual statistical parametric maps. All supra-
threshold voxels in a statistical parametric map are
partitioned into clusters of contiguous (touching) voxels.
SPM2 calculates probability values for the spatial extent of
each cluster (size in voxels) and the strength of the effect
at each individual voxel. The multiple comparisons prob-
lem is addressed using continuous random field theory,
assuming the statistic image to be a good lattice represen-
tation of an underlying continuous stationary random




Mean ages (95%CI) did not differ significantly between
the moxibustion (47.5 years [41–53]) and control groups
(40.9 years [35-47]). Mean weight and height in respect-
ive groups were 66 kg (63–69) and 167 cm (162–172)
versus 68 kg (62–74) and 169 cm (164–174). The diseaseFigure 4 Pain score in both groups during 100 ml rectal
balloon distention.course of D-IBS in respective groups was 3 years (2–5)
and 3.5 years (3–10)(Table 1).
Birmingham IBS symptom scale and IBS QOL scale
In the moxibustion group, the Birmingham IBS Symp-
tom Scale and IBS QOL Scale scores significantly de-
creased, from 28.27 ± 6.64 to 9.00 ± 4.05 (P < 0.01) and
80.33 ± 8.49 to 48.27 ± 7.69 (P < 0.01), respectively, after
treatment. In the control group, the Birmingham IBS
Symptom Scale and IBS QOL Scale scores significantly
decreased, from 27.38 ± 3.95 to 21.46 ± 4.31 (P < 0.01)
and 80.54 ± 8.27 to 70.62 ± 7.42 (P < 0.01), respectively,
after treatment. The decreases in the Birmingham IBS
Symptom Scale and IBS QOL Scale scores in the moxi-
bustion group was significantly greater than those in the
control group (P < 0.01) (Table 2, Table 3).
Rectal distention threshold
Before treatment, the rectal distention thresholds in both
groups were not significantly different. After treatment,
the first sensation threshold in both groups was not sig-
nificantly different. The defecation urge threshold of the
moxibustion group after treatment was significantly higher
than that of baseline (P < 0.01). However, in the control
group, there was no significant change after treatment.
The pain detection threshold after moxibustion was sig-
nificantly higher than baseline (P < 0.01). The pain detec-
tion threshold increased in the control group but was not
statistically significant (Table 4).
The pain score of the moxibustion group during the
50 ml rectal balloon distention decreased from 2.63 ± 0.30
to 2.0 ± 0.15 after treatment (P > 0.05). In the control
group, it decreased from 2.62 ± 0.27 to 2.12 ± 0.23 after
treatment (P > 0.05). There was no difference between the
two groups. The pain score during the 100 ml rectal bal-
loon distention in the moxibustion group after treatment
Table 5 Brain regions significantly activated during 50 ml rectal balloon distention in both groups
Moxibustion Group (n = 15) Control Group (n = 13)
Before Treatment After Treatment Before Treatment After Treatment
XYZ BA T P X Y Z BA T P XYZ BA T P X Y Z BA T P
Prefrontal Cortex None −20 64 -12 ---- 5.11 0 None −38 38 -16 ---- 5.64 0.001
−20 60 -20 11 4.9 0 −28 28 -20 ---- 4.13 0.001
6 36 30 9 4.49 0.004 −36 14 36 9 5.87 0.002
14 22 60 6 3.56 0.997
Anterior Cingulate Cortex None None None −2 -42 30 31 5.36 0.002
−6 -52 8 30 4.79 0.002
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control group, it decreased from 5.89 ± 0.42 to 4.96 ± 0.34
(P > 0.05). The decrease in pain score during the 100 ml
rectal balloon distention in the moxibustion group was sig-
nificantly greater than that of the control group (P < 0.05)
(Figure 3, Figure 4).
Brain fMRI
There was no brain activation in either group during the
50 ml rectal balloon distention. After treatment, the pre-
frontal cortex (PFC) was activated in the moxibustion
group, while the PFC and anterior cingulated cortex
(ACC) were activated in the control group (Table 5).
During the 100 ml rectal balloon distention before
treatment, the PFC and ACC were activated. After treat-
ment, there was no activation of the PFC or ACC in the
moxibustion group. However, these areas were still acti-
vated in the control group, although the specific coordi-
nates of those areas were different from the baseline
(Table 6, Figure 5, Figure 6, Figure 7 and Figure 8).
Discussion
The increased visceral sensitivity in the pathophysiology of
IBS patients has received much attention recently. Our re-
sults demonstrate the clinical effects of moxibustion onTable 6 Brain regions significantly activated during 100 ml re
Moxibustion Group (n = 15)
Before Treatment After treatment
Prefrontal Cortex X Y Z BA T P XYZ BA T
26 40 -24 11 4.98 0.000 6 60 -6 10 3.6
26 72 -8 10 5.2 0.000
52 50 -10 47 7.06 0.000
52 34 34 9 6.91 0.000
52 46 40 46 6.31 0.000
50 22 -6 47 3.69 0.000
−12 -14 60 6 3.86 0.008
Anterior Cingulate Cortex 10 30 -12 32 5.82 0.000 4 -52 24 31 3.6D-IBS. They also show that the initial perception thresh-
old, urgent defecation perception threshold, and pain per-
ception thresholds of the rectum in two groups of patients
before treatment were similar to those in another report
[27]. After aconite-separated moxibustion treatment, the
defecation urge threshold and pain detection threshold
were increased while the pain score after a 100 ml rectal
balloon distention was decreased. Therefore, after aconite-
separated moxibustion treatment, the rectal sensitivity of
D-IBS patients decreased. Moreover, the critical efficacy of
aconite-separated moxibustion might be associated with
reduced rectal sensitivity.
The development of brain imaging has greatly enhanced
the ability to investigate brain–gut interactions and to as-
sess the central nervous system’s role on visceral pain per-
ception. The results of studies using brain imaging in IBS
have demonstrated differences in brain activation between
patients with IBS and healthy controls [28]. Previous stud-
ies have found that IBS patients seem to have different vis-
ceral sensory areas from normal controls [29]. Moreover,
the blood flow, glucose metabolic rate, or potential activities
of the cerebral cortex in patients with IBS are not the same
as those in control groups [30,31]. Studies have shown that
anterior cingulate cortex (ACC), PFC, inferior colliculus
(IC), and thalamus are activated in the non-painful andctal balloon distention in both groups
Control Group (n = 13)
Before Treatment After treatment
P X Y Z BA T P X Y Z BA T P
2 0.993 58 24 12 45 6.03 0.001 −24 40 -16 ---- 3.36 0.024
−24 64 -8 10 5.19 0.006 54 -2 24 6 3.6 0.048
−22 38 46 8 4.95 0.005 −12 46 6 ---- 3.51 0.05
−52 18 0 47 4.16 0.042
−38 34 -14 11 3.74 0.042
2 0.991 18 34 16 ---- 4.32 0.049 −20 -66 10 30 4.99 0.001
10 -20 34 ---- 3.99 0.042
Figure 5 Functional magnetic resonance imaging in moxibustion group before and after treatment during 100 ml rectal balloon
distention: A-before treatment, B-after treatment.
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[29]. Results of functional neuroimaging studies in IBS
patients show variable results but increased regional ac-
tivity in the insula (INS) and anterior midcingulate cortex
(aMCC) are most commonly reported [32]. Hypersensi-
tive IBS patients had more dorsolateral prefrontal cor-
tex (DLPFC) activation than normosensitive patients
[22]. In a study of rectal distension, pain, or discomfort,
patients with IBS have fairly variable differences in acti-
vated brain regions compared with controls, generally
comprising divisions of the PFC, ACC, MCC, insula,Figure 6 Functional magnetic resonance imaging chart in control gro
distention: A-before treatment, B-after treatment.amygdala, hypothalamus, and brainstem nuclei [33].
Ran Jun Tao et al. found that the visceral hypersensitiv-
ity center of Chinese IBS patients might be the IC and
PFC [27]. In our study, for both groups of patients, a
significant activation was observed during the 50 and
100 ml rectal balloon distention in the ACC and PFC.
Activation was seen in other brain areas, such as tem-
poral lobe, primary visual cortex, cerebellum, but there
is no difference between moxibustion group and con-
trol group in these areas. They were not examined fur-
ther in this study.up before and after treatment during 100 ml rectal balloon
Figure 7 Functional magnetic resonance imaging in activated
PFC and ACC in moxibustion group during 100 ml rectal
balloon distention. Upper row are the pictures before treatment,
lower row are the pictures after treatment. The prefrontal cortex
(PFC) and anterior cingulated cortex(ACC) are encircled. Left row is
PFC and right row is ACC.
Figure 8 Functional magnetic resonance imaging of activated PFC
and ACC in control group during 100 ml rectal balloon distention.
Upper row is the pictures before treatment, lower row is the pictures
after treatment. PFC (left row) and ACC (right row) are encircled.
Zhu et al. BMC Complementary and Alternative Medicine 2014, 14:500 Page 10 of 12
http://www.biomedcentral.com/1472-6882/14/500CH Wilder-Smith et al. [34] showed that brain activation
changes during heterotopic stimulation differed highly sig-
nificantly between constipation predominant IBS(IBS-C),
IBS-D, and controls. The main centres affected were the
amygdala, anterior cingulate cortex(ACC), hippocampus,
insula, periaqueductal gray, and prefrontal cortex(PFC),
which form part of the matrix controlling emotional, auto-
nomic, and descending modulatory responses to pain.
Winnie CW Chu et al. [35] found that rectal distention
induced significant activation of the anterior cingulated
cortex(ACC), prefrontal cortex(PFC), thalamus, temporal
regions and cerebellum of D-IBS. In our study, after
aconite-separated moxibustion treatment, activation of the
PFC and ACC during the 100 ml rectal balloon distention
was not seen when compared with the control group.
Visceral hyperalgesia was accompanied by activation of
more PFC areas [36]. Meanwhile, the ACC is considered a
key element in the rostral limbic system [37]. Relative to
controls, IBS participants showed heightened activation of
the ACC, IC, and ventral medial prefrontal regions, sug-
gesting heightened affective responses to painful visceral
stimuli [38]. The visceral sensory nerve center contains a
regulatory network system, which is composed of the PFC,
limbic system including the cingulate gyrus, IC, andthalamus [39]. The formation and sensitivity of the visceral
sensory center are closely related to this network system.
An altered visceral sensitivity through abnormal endogen-
ous pain processing plays an important role in the patho-
genesis of IBS [40]. After aconite-separated moxibustion,
the disappearance of PFC and ACC activation may imply
that this kind of treatment can decrease affective responses
to painful visceral stimulation and down-regulate the influ-
ence on the visceral hypersensitivity. This may partially
explain a neurobiological mechanism of how aconite-
separated moxibustion treatment relieves abdominal pain,
bloating, or discomfort in D-IBS patients.
Our study showed that during a 50 ml rectal balloon
distention, the activation of the PFC and ACC increased
after treatment in both groups. Previous study had shown
that the fMRI signal rangeability of insula cortex(IC) and
PFC increased with the strength of the rectal balloon
stimulus but statistical significance was only found when
the distention was above 90 ml [27]. In our study, 50 ml
rectal balloon distention is a stimulation under pain
threshold, its significance remains further research. The
PFC and ACC were both activated before and after
placebo moxibustion treatment during the 100 ml rectal
balloon distension. Although the activation coordinates
were not the same, they all belong to the same anatomical
structures. Before and after stimulation, both the ACC
Zhu et al. BMC Complementary and Alternative Medicine 2014, 14:500 Page 11 of 12
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were subtly different. Whether the response will appear
from different brain cell populations at different times for
the same stimulation needs further study.
In recent years, many studies have been performed using
fMRI to investigate the cerebral matrix related to acupunc-
ture therapy [41,42]. Acupuncture has a coordinated effect
on a network of cortical and subcortical limbic and
paralimbic structures in the human brain [43]. Acupunc-
ture also produces extensive deactivation of the limbic-
paralimbic-neocortical system [44]. An fMRI study on IBS
patients with acupuncture therapy resulted in differential
activation of the right insula and pulvinar and medial nu-
cleus of the thalamus after EA treatment [35]. However,
there is no brain imaging research on moxibustion.
Moxibustion is an important external treatment used
within traditional Chinese medicine that has few side ef-
fects. The Inner Canon of Yellow Emperor Miraculous Pivot
states that, “When needles are not having effect, may moxi-
bustion the appropriate treatment.” In our study, the acu-
point combination (ST25, RN6, RN12) was used, and these
points were chosen to tonify the spleen and stomach. One
recent study of an abdominal acupuncture method includ-
ing points RN6 and RN12 showed improvement in allomet-
ric function of the brain cognition network of the central
nervous system [45]. However, whether moxibustion has
the same mechanism as needles is still unknown. Because
experimental and clinical evidence indicates that most acu-
puncture effects are mediated by the brain, a brain imaging
study on moxibustion should be informative. Previous acu-
puncture fMRI studies have mostly investigated the effects
of stimulating one or two acupoints simultaneously [46].
However, we observed comparison imaging of D-IBS pa-
tients before and after consecutive moxibustion treatment
sessions.
This study has some potential weaknesses. First, the
sample size is limited. The current data need to be con-
firmed with a larger patient population. Second, manual
volume-based distensions rather than barostat pressure
controlled inflations were used because of equipment limi-
tations. In further studies, a barostat pressure measure-
ment should improve the accuracy of the experiment.
Third, the definite activity of neurons in the PFC and
ACC are not known. We can only reveal the mechanism
of aconite-separated moxibustion using fMRI. With more
standardized IBS distension protocols and advanced im-
aging techniques [47] we could further understand the
mechanisms of moxibustion for D-IBS patients.
Conclusions
Moxibustion can improve the symptoms and quality of
life in D-IBS patients and decrease rectal sensitivity. The
mechanism may involve the regulation of abnormal en-
dogenous pain processing in D-IBS. Our results providesupport of the clinical use of moxibustion for the treat-
ment of D-IBS.
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